Management ChangeMay 26, 2026, 08:02 AM
CG Oncology President & COO Bellete Departs; Kuan Appointed President
AI Summary
CG Oncology announced the separation of Ambaw Bellete, its President & Chief Operating Officer, effective June 30, 2026. Concurrently, the Board of Directors appointed Arthur Kuan as President, in addition to his other positions, effective May 20, 2026. The company expects to enter into a separation agreement with Mr. Bellete, providing severance benefits as per his employment agreement, and has initiated a search for a Chief Commercial Officer.
Key Highlights
- Ambaw Bellete to separate from CG Oncology as President & Chief Operating Officer.
- Mr. Bellete's separation is effective June 30, 2026.
- Arthur Kuan appointed as President of CG Oncology.
- Mr. Kuan's appointment as President was effective May 20, 2026.
- The company expects to provide severance benefits to Mr. Bellete.
- CG Oncology has initiated a search for a Chief Commercial Officer.
Price Impact
More from CGON